Hsiuyi Tseng

Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma

William M. Lin, Alissa C. Baker, Rameen Beroukhim et al. · Cancer Research · 2008 · 296 citations · Full text

Medicine, Molecular Biology, Oncology +17

Attainment of complete/very good partial response following rituximab‐based therapy is an important determinant to progression‐free survival, and is impacted by polymorphisms in <i>FCGR3A</i> in Waldenstrom macroglobulinaemia

Steven P. Treon, Guang Yang, Christine Hanzis et al. · British Journal of Haematology · 2011 · 74 citations

Medicine, Immunology, Oncology +15

Hepcidin Is Produced by Lymphoplasmacytic Cells and Is Associated With Anemia in Waldenström's Macroglobulinemia

Bryan Ciccarelli, Christopher J. Patterson, Zachary R. Hunter et al. · Clinical Lymphoma Myeloma & Leukemia · 2011 · 36 citations

Medicine, Hematology, Immunology +6

Soluble CD27 Is a Faithful Marker of Disease Burden and Is Unaffected by the Rituximab-Induced IgM Flare, as Well as by Plasmapheresis, in Patients with Waldenström's Macroglobulinemia

Bryan Ciccarelli, Guang Yang, Evdoxia Hatjiharissi et al. · Clinical Lymphoma & Myeloma · 2009 · 22 citations

Life Sciences, Immunology, Clinical Immunology +12

Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia.

Jenny Sun, Lian Xu, Hsiuyi Tseng et al. · Blood · 2009 · 22 citations

Medicine, Oncology, Pharmacology +11